These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Enterococcal infective endocarditis: description of 12 cases]. Martínez Odriozola P; Muñoz Sánchez J; Arriola Martínez P; Lizarralde Palacios E; Santamaría Jáuregui JM; Zuazo Meabe J; Cisterna Cáncer R; de la Villa FM An Med Interna; 2007 Nov; 24(11):539-42. PubMed ID: 18275263 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800 [TBL] [Abstract][Full Text] [Related]
5. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children. Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316 [TBL] [Abstract][Full Text] [Related]
6. A surveillance of high-level gentamicin-resistant enterococcal bacteremia. Araoka H; Kimura M; Yoneyama A Kansenshogaku Zasshi; 2012 Mar; 86(2 Suppl 4):27-8. PubMed ID: 23115941 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251 [TBL] [Abstract][Full Text] [Related]
8. A surveillance of high-level gentamicin-resistant enterococcal bacteremia. Araoka H; Kimura M; Yoneyama A J Infect Chemother; 2011 Jun; 17(3):433-4. PubMed ID: 21042826 [TBL] [Abstract][Full Text] [Related]
9. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine]. Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808 [TBL] [Abstract][Full Text] [Related]
10. Teicoplanin for treating enterococcal infective endocarditis: A retrospective observational study from a referral centre in Spain. Escolà-Vergé L; Fernández-Hidalgo N; Rodríguez-Pardo D; Pigrau C; González-López JJ; Bartolomé R; Almirante B Int J Antimicrob Agents; 2019 Feb; 53(2):165-170. PubMed ID: 30315920 [TBL] [Abstract][Full Text] [Related]
11. [Aminoglycosides in the treatment of infectious endocarditis]. Malinverni R Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414 [TBL] [Abstract][Full Text] [Related]
15. [Enterococcal endocarditis: a multicenter study of 76 cases]. Martínez-Marcos FJ; Lomas-Cabezas JM; Hidalgo-Tenorio C; de la Torre-Lima J; Plata-Ciézar A; Reguera-Iglesias JM; Ruiz-Morales J; Márquez-Solero M; Gálvez-Acebal J; de Alarcón-González A; Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):571-9. PubMed ID: 19477041 [TBL] [Abstract][Full Text] [Related]
16. Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study. Venditti M; Tarasi A; Capone A; Galié M; Menichetti F; Martino P; Serra P J Antimicrob Chemother; 1997 Sep; 40(3):449-52. PubMed ID: 9338503 [TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci. Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526 [TBL] [Abstract][Full Text] [Related]
18. Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children. Capitano B; Quintiliani R; Nightingale CH; Nicolau DP Paediatr Drugs; 2001; 3(10):703-18. PubMed ID: 11706922 [TBL] [Abstract][Full Text] [Related]
19. Prosthetic biologic valve endocarditis caused by a vancomycin-resistant (vanA) Enterococcus faecalis: case report. Carfagna P; Tarasi A; Cassone M; Del Grosso MF; Bianco G; Venditti M J Chemother; 2000 Oct; 12(5):416-20. PubMed ID: 11128562 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy. Cerón I; Muñoz P; Marín M; Segado A; Roda J; Valerio M; Bouza E; J Antimicrob Chemother; 2014 Jun; 69(6):1669-74. PubMed ID: 24532682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]